ACR Convergence 2023

November 10-15, 2023. San Diego, CA.

View by Number View by Title View Sessions

Abstract Number: 2079

Comparative Analysis of Teledidactic and On-Campus Training in Musculoskeletal Ultrasound – the TELMUS Study
Abstract Number: 2080

Implementation of a Clinically-Focused Online Journal Club in Rheumatology: Experience from TheMednet
Abstract Number: 2081

Harnessing the Power of Social Media for Good: Using Instagram as a Formative Assessment Tool
Abstract Number: 2082

Delivery of Rheumatology Education to Internal Medicine Residents in Rwanda: Evaluation of a New Virtual Rheumatology Course Supplemented by On-site Clinical Teaching
Abstract Number: 2083

Compiled Verbal Feedback as a Novel Mechanism for Faculty Feedback from Rheumatology Fellows-in-Training
Abstract Number: 2084

Enhancing Internal Medicine Curriculum: Key Rheumatology Themes in Inpatient Setting
Abstract Number: 2085

A Survey on Giant Cell Arteritis-Related Knowledge Among Internal Medicine Residents
Abstract Number: 2086

From Fellow to Fellowship Director: Gender Equity in Pediatric Rheumatology Pipeline
Abstract Number: 2087

Racial and Ethnic Diversity in Pediatric Fellowships: Fortifying the Pipeline
Abstract Number: 2088

Room for Racial and Ethnic Diversity in Adult Rheumatology Fellowship Pipeline
Abstract Number: 2089

Social Listening Analysis of IgG4-Related Disease Social Media Discussions
Abstract Number: 2090

Adaptation of the Making it WorkTM for People with Systemic Sclerosis
Abstract Number: 2091

Reach and Representativeness of Participants in an Evidence-Based, Community-Delivered Physical Activity Intervention in Adults with Arthritis
Abstract Number: 2092

Feasibility and Efficacy of Culturally Appropriate Spanish Language-First Patient Education for Rheumatoid Arthritis
Abstract Number: 2093

Meeting the Educational and Language Needs of the Lupus Community: A Snapshot of 2022 Lupus Inquiries

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].